Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group.
about
Comprehensive tumor profiling identifies numerous biomarkers of drug response in cancers of unknown primary site: analysis of 1806 cases.Cancer of Unknown Primary in Adolescents and Young Adults: Clinicopathological Features, Prognostic Factors and Survival Outcomes.Germline genetics of cancer of unknown primary (CUP) and its specific subtypesPrognostic significance of WNT and hedgehog pathway activation markers in cancer of unknown primary.
P2860
Mutational profiling of the RAS, PI3K, MET and b-catenin pathways in cancer of unknown primary: a retrospective study of the Hellenic Cooperative Oncology Group.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh
2014年學術文章
@zh-hant
name
Mutational profiling of the RA ...... ic Cooperative Oncology Group.
@en
Mutational profiling of the RA ...... ic Cooperative Oncology Group.
@nl
type
label
Mutational profiling of the RA ...... ic Cooperative Oncology Group.
@en
Mutational profiling of the RA ...... ic Cooperative Oncology Group.
@nl
prefLabel
Mutational profiling of the RA ...... ic Cooperative Oncology Group.
@en
Mutational profiling of the RA ...... ic Cooperative Oncology Group.
@nl
P2093
P2860
P1476
Mutational profiling of the RA ...... ic Cooperative Oncology Group.
@en
P2093
A Cervantes
E A Kotteas
E Charalambous
G Pentheroudakis
K Papadopoulou
N Pavlidis
T Ciuleanu
P2860
P2888
P304
P356
10.1007/S10585-014-9666-1
P577
2014-07-05T00:00:00Z